3MYJ
Human Class I MHC HLA-A2 in complex with the WT-1 (126-134) (R1Y) peptide variant.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 19-ID |
Synchrotron site | APS |
Beamline | 19-ID |
Temperature [K] | 100 |
Detector technology | CCD |
Wavelength(s) | 0.97929 |
Spacegroup name | P 1 |
Unit cell lengths | 50.202, 62.826, 74.755 |
Unit cell angles | 81.91, 75.90, 77.94 |
Refinement procedure
Resolution | 20.000 - 1.890 |
R-factor | 0.188 |
Rwork | 0.185 |
R-free | 0.23000 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1tvb |
RMSD bond length | 0.020 |
RMSD bond angle | 1.877 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | MOLREP |
Refinement software | REFMAC |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.000 | 1.930 |
High resolution limit [Å] | 1.890 | 1.890 |
Rmerge | 0.063 | 0.419 |
Number of reflections | 66006 | |
<I/σ(I)> | 14.5 | 2 |
Completeness [%] | 96.9 | 95.9 |
Redundancy | 1.9 | 1.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 277 | PEG3350 24%, MES 0.025M, KCl 0.1M, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K |